Johnson & Johnson (JNJ) to Release Quarterly Earnings on Tuesday
Johnson & Johnson (NYSE:JNJ) will be announcing its Q313 earnings results on Tuesday, October 15th. Analysts expect the company to announce earnings of $1.32 per share and revenue of $17.41 billion for the quarter. Johnson & Johnson has set its FY13 guidance at $5.40-5.47 EPS.
Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Tuesday, July 16th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.09. The company had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $17.71 billion. During the same quarter in the previous year, the company posted $1.30 earnings per share. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. On average, analysts expect Johnson & Johnson to post $5.46 EPS for the current fiscal year and $5.81 EPS for the next fiscal year.
Shares of Johnson & Johnson (NYSE:JNJ) opened at 89.45 on Monday. Johnson & Johnson has a one year low of $68.07 and a one year high of $94.42. The stock has a 50-day moving average of $87.67 and a 200-day moving average of $87.14. The company has a market cap of $252.1 billion and a price-to-earnings ratio of 19.49.
A number of analysts have recently weighed in on JNJ shares. Analysts at Goldman Sachs Group Inc. upgraded shares of Johnson & Johnson from a “sell” rating to a “neutral” rating in a research note to investors on Friday. They now have a $95.00 price target on the stock, up previously from $87.00. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Johnson & Johnson in a research note to investors on Friday, August 30th. They now have a $91.00 price target on the stock. Finally, analysts at Thomson Reuters/Verus upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating in a research note to investors on Monday, August 12th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company. Johnson & Johnson currently has an average rating of “Hold” and a consensus target price of $88.29.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.